Dilemma of Prioritising Health and the Economy During COVID-19 Pandemic in Indonesia.
Siti Setiati, Muhammad Khifzhon Azwar
2020
31
en
2
Siti Setiati, Muhammad Khifzhon Azwar
2020
31
en
2
Since the detection of the first confirmed case of coronavirus disease 2019 (COVID-19) in early March 2020, 248,852 cases have been detected in Indonesia by 21 September 2020. At least 100 doctors have died from COVID-19 nationwide. Full large-scale social restriction was a temporary measure, followed by an early transition to the new normal era during the never-ending first wave in the country. Workers in industrial, retail, transport, and tourism fields suffered a significant decrease in work. Many countries are, however, in dilemma of protecting the health of the citizens and prioritising economy. Health should be prioritised because it is an important aspect of our lives for our economy. Poor health is estimated to reduce global gross domestic product (GDP) by 15% annually through premature deaths and potential loss of productivity of the working-age citizens. Pandemics also depress economy through decrease in both supply and demand. Data from flu pandemic a century ago suggested the importance of aggressiveness and speed of intervention. Taiwan's early action led to beneficial effects on SARS-CoV-2 infection rate and economy recovery. The target of enhancement of containment measures, provision of personal protective equipments, and testing and isolation facilities should be achieved earlier and be more than the projected demand.
— Terkait
Qiongni Chen, Mining Liang, Yamin Li, Jincai Guo, Dongxue Fei et al.
The Lancet Psychiatry · Elsevier BV
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai‐Hin Chung et al.
The Lancet · Elsevier BV
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, Milena Sokołowska, Willem van de Veen et al.
Allergy · Wiley
As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked
Majid Assadi, Ali Gholamrezanezhad, Narges Jokar, Mohsen Keshavarz, Maria Picchio et al.
European Journal of Nuclear Medicine and Molecular Imaging · Springer Science+Business Media
Konstantin Stark, Steffen Maßberg
Nature Reviews Cardiology · Nature Portfolio
Sonja A. Rasmussen, John C. Smulian, John A. Lednicky, Tony Wen, Denise J. Jamieson
American Journal of Obstetrics and Gynecology · Elsevier BV